Several viruses representing different families and, in some instances, multiple serotypes for each virus have been associated with bovine respiratory tract diseases (44) . These viruses include: bovine herpesvirus type 1 (BHV-1), also known as infectious bovine rhinotracheitis virus; bovine viral diarrhea virus (BVDV); parainfluenza type 3 virus (Pl-3V); bovine respiratory syncytial virus (BRSV); bovine adenoviruses (BAV); DN-599 and FTC 2 bovine herpesviruses; rhinoviruses; influenza virus; and enteroviruses. Licensed vaccines are available in the United States for only BHV-1, PI-3V, and BVDV. At present there are no licensed antiviral drugs for use in food-producing animals.
Interferon (IFN) has been detected in the serum and nasal and vaginal secretions of cattle inoculated with BHV-1 (1, 10-12, 26, 29, 48, 49, 52, 53, 57) . In addition, cattle inoculated intranasally with BAV-3, PI-3V, or a bovine rhinovirus had nasal secretion IFN postchallenge (10) (11) (12) 39) . IFN in serum was detected in calves aerosolized with BRSV (15) . A temporal relationship between IFN in respiratory tract secretions and onset of protection against virulent BHV-1 challenge has been reported (53) . However, another study indicated that nasal IFN did not protect calves against virulent BHV-1 challenge (49) . Calves with IFN in their nasal secretion subsequent to inoculation with a vaccinal strain of BHV-1 had decreased viral yield in nasal secretions for BAV-3, PI-3V, and a bovine rhinovirus compared with the viral yield of calves not receiving vaccinal BHV-1 (10) (11) (12) 39) .
The results of several studies suggest that bovine IFN may protect against infection or at least reduce the clinical severity of infection with certain viruses. In vivo, there may be other host defense mechanisms which afford protection besides or in combihation with IFN. Thus, it would be advantageous to test the protective role of IFN in an in vitro system. In vitro systems permit screening of compounds for possible further in vivo testing, detection of optimal IFN concentrations required for antiviral activity, and determination of the relative sensitivity of various viruses to antiviral effects.
This study reports on antiviral effects of bovine IFN when applied to bovine turbinate monolayer cultures which were challenged with bovine respiratory tract viruses.
MATERIALS AND METHODS Cell cultures. Monolayer cultures used included: bovine turbinate (BT) (19) , ovine fetal turbinate (18) , bovine dermal (obtained from Cell Culture Laboratory, Naval Biomedical Research Laboratory, Oakland, Calif.), and bovine fetal kidney (BFK) (10) . The growth and maintenance media have been previously described (19) . Cultures were incubated at 37°C in a humidified incubator.
Viruses. Stock BHV-1 included: Cooper strain (18), Los Angeles strain (19) , Colorado I vaccinal (23), nasal vaccinal strain-A (23, 53), nasal vaccinal strain-B (26), BRD 37 (21) , BRD 38 (21) , and (8) 81B-3101, isolated from nasal secretions of an adult bull with respiratory tract disease (Louisiana State University Veterinary Medical Teaching Hospital and Clinics, Baton Rouge). These viruses were grown and processed as described previously (19) . BHV-1 were grown in BT cells and titrated by plaque assay in bovine dermal cultures (19) . Titers were expressed as PFU/0.5 ml.
The other stock viruses included: BVDV, Singer strain (18); PI-3V, SF-4 strain (18); BRSV (375 strains) (35) ; goat respiratory syncytial virus (GRSV) (18) ; BAV-7 (18); and vesicular stomatitis virus, Indiana strain (VSV) (23) . BVDV, PI-3V, and BAV-7 were grown in BT cells (18) and titrated in 96-well microtiter cell cultures (6, 18) . BRSV and GRSV were grown in ovine fetal turbinate cells (18) and titrated in 96-well microtiter cell cultures (6, 18) . Median tissue culture 50% infective doses (TCID50) per 0.025 ml were determined by the Spearman-Karber method (6) . VSV was grown, processed, and titrated by plaque assay as described previously (19) .
IFN. IFN used in this study included bluetongue virus serotype 10 (BTV) induced in Georgia bovine kidney (GBK) monolayers (20) , (6) . Ten-fold dilutions were made (10-1 was the lowest dilution tested), and four wells were used per dilution. Assays for virus controls and IFN treatment were performed concurrently for each virus in a particular experiment. All assays for viral infectivity were performed in ovine fetal turbinate cells, except those for BAV-7 which were performed in BT cells. Microtitrations were observed daily, and the final reading for CPE was made 7 days after inoculation. Viral yields were expressed as loglo TCID50 per 0.025 ml. If CPE was not evident in any of the four wells or was evident in only one well of the 10' dilution, this was recorded as <1.00 of log10 TCID50 per 0.025 ml.
RESULTS
In vitro sensitivity of BHV-1 strains, PI-3V, BRSV, GRSV, BVDV, BAV-7, and VSV to bovine IFN. BT cells incubated with IFN 18-to 24-h before challenge with 102 or 103 PFU of BHV-1 strains had yield reductions in the 24-h collection compared with cultures not receiving IFN (control cultures) ( Table 1 ). In several instances there were lower levels of infectivity in cultures receiving IFN in the postchallenge media. All eight BHV-1 strains tested in this study were susceptible to the antiviral effects of IFN. BT cultures treated with bovine IFN before challenge with PI-3V, BRSV, GRSV, BVDV, BAV-7, or VSV had yield reductions compared with viral yields of control cultures (Tables 2  through 7) . DISCUSSION There have been several previous studies indicating that various bovine viruses were susceptible to IFN. However, each of these studies usually examined antiviral activity against only one virus. In addition, IFN concentrations, sources of IFN, culture conditions, and infectivity assays may have differed between these studies. The results described for the present study indicate that exogenously applied bovine IFN samples have an antiviral effect in BT cells and also that several viruses are susceptible to the antiviral effects of these IFN. All viruses in this study were sensitive to IFN. including eight BHV-1 strains, PI-3V, BRSV, GRSV, BVDV, BAV-7, and VSV. VSV was utilized as a control because of its sensitivity to various IFN. BHV-1, PI-3V, BRSV, BVDV, and BAV-7 have all been associated with bovine respiratory tract diseases.
In the present study there was, in almost all instances, less viral infectivity in virus-infected cultures treated with IFN than in control cultures. However, the method of assay for infectivity, loglo dilutions with four wells per dilution, may not have quantitated the significant differences, due to the potential error of 0.5 to 1.5 log1o for this assay. In the present study, each virus had individual assays in which there were 1.5 or greater loglo reductions. It is possible that these differences would have been better demonstrated if the plaque reduction method had been used. Also, the antiviral effects of IFN might have been more evident if, after IFN treatment and after viral challenge, collections had been made after single-replication cycles rather than after multiple-replication cycles.
In the present study, antiviral activity was evident for several days after IFN was removed, thus permitting multiple-replication cycles for these viruses. However, in other studies the antiviral state decayed rapidly in cell cultures after IFN removal (5, 33 ). Yet in another study, the antiviral state persisted for at least 72 h after removal of IFN (28) . Several studies have shown that different viruses exhibit different sensitivities to IFN-induced resistance in the same cell when measured by single-and multiple-cycle assays (24, 51, 56) . Hallum et al. (27) have shown that in the same cell the antiviral state is lost at different rates for different viruses. Similarly in the present study, there may have been varied responses due to the differences associated with the several viruses used.
There have been several reports of in vitro susceptibility in bovine cells to bovine IFN for BHV-1, PI-3V, BVDV, and a bovine rhinovirus. Antiviral activity against BHV-1 was demonstrated in BFK cultures by bovine serum IFN (47); BHV-1 induced IFN from bovine fetal spleen cultures, bovine peripheral blood leukocytes and bovine alveolar macrophages; and phytohemagglutinin induced peripheral blood leukocyte IFN (23) . Supernatant fluids from BHV-1-infected bovine alveolar macrophages (centrifuged to remove BHV-1) interfered with BHV-1 infection of alveolar macrophage cultures (17) . Bovine alveolar macrophage IFN reduced BHV-1 yield in tracheal explant cultures derived from adult cattle (22) , and BHV-1 antigen-stimulated lymphocyte culture supernatant caused a transitory yield reduction in bovine fetal tracheal organ cultures (8) . Bovine immune IFN reduced BHV-1 yields in GBK monolayers (4) . PI-3V-induced BFK culture IFN had antiviral activity against PI-3V in BFK cultures (46) , and PI-3V was inhibited by IFN induced by PI-3V in bovine embryonic kidney cells (54) . BVDV was sensitive to the antiviral effects of Newcastle disease virus-induced calf kidney IFN (14) . Calf kidney IFN protected calf tracheal organ cultures against a bovine rhinovirus (50).
Not all studies have indicated that PI-3V and BHV-1 were sensitive to IFN under the experimental conditions used (49, 54) . PI-3V was inhibited by Newcastle disease virus-and influenza virus-induced IFN in chicken embryo fibroblast cells, but PI-3V was not inhibited by IFN produced in bovine embryonic kidney cells induced by BHV-1, Newcastle disease virus, or influenza virus (54) . Also in that study, BHV-1 was not inhibited by IFN produced by bovine embryonic kidney or chicken embryo fibroblasts exposed to BHV-1, Newcastle disease virus, PI-3V, or influenza virus (54) . In another study, nasal secretion IFN from calves vaccinated with a commercial intranasal BHV-1 vaccine was added to " Treatment was the same as that described in c except the IFNcontaining medium in the pretreatment wells was returned to the wells for posttreatment.
38, 41, 43, 45) , herpesvirus platyrrhine (13) , herpesvirus saimiri (13), herpesvirus ateles (13), varicella zoster virus (3, 38, 41) , Medical Lake macque herpesvirus (41) , and cytomegaloviruses (38, 42) . Another bovid herpesvirus, bovine mammillitis virus (BHV-2), was susceptible to BHV-2-induced bovine IFN (37) .
There does not appear to be strain variation of BHV-1 for Human respiratory syncytial virus, related antigenically to BRSV, has been reported to be sensitive to human IFN (7, 9, 25, 40) and polyinosinic acid-polycytidylic acid (29) . In one study, differences in the antiviral activity of IFN produced by human macrophages exposed to different viruses, influenza or respiratory syncytial virus, were demonstrated (7). In that study, respiratory syncytial virus was more sensitive to respiratory syncytial virus-induced IFN activity than to influenza virus-induced IFN activity. In the present study, 
